We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Expression of Stem Cell Gene Restores Contractile Function to Aged Muscle Cells

By LabMedica International staff writers
Posted on 08 Aug 2016
Transplanting a stem cell gene into aged muscle cells reversed many indicators of cellular senescence and completely restored the cells' ability to generate contractile force.

Cellular senescence as a result of aging or progeroid diseases, such as Hutchinson-Gilford progeria syndrome, leads to stem cell pool exhaustion that hinders tissue regeneration and contributes to the progression of age related disorders. More...
Furthermore, the ability of adult stem cells to form muscle and generate force declines with aging.

Investigators at the University at Buffalo (NY, USA) examined the possibility of reversing the aging process by transplanting the NANOG gene into aged muscle cells. NANOG is a transcription factor in embryonic stem cells (ESCs) that is thought to be a key factor in maintaining pluripotency.

The investigators inserted NANOG into cells from three different models of aging: cells isolated from aged donors, cells aged in culture, and cells isolated from patients with Hutchinson-Gilford progeria syndrome. They reported in the July 11, 2016, online edition of the journal Stem Cells that expression of NANOG in senescent or progeroid muscle progenitor cells reversed cellular aging and restored completely the ability to generate contractile force.

NANOG worked this magic by enabling reactivation of the Rho-associated protein kinase (ROCK) and transforming growth factor (TGF)-beta pathways - both of which were impaired in senescent cells. Reactivation of these pathways stimulated dormant proteins (actin) to generate cytoskeletons that adult stem cells need to form contractile muscle cells and activated the central regulator of muscle formation, serum response factor (SRF).

"Our research into Nanog is helping us to better understand the process of aging and ultimately how to reverse it," said senior author Dr. Stelios T. Andreadis, professor of chemical and biological engineering at the University at Buffalo. "Not only does Nanog have the capacity to delay aging, it has the potential in some cases to reverse it."

Related Links:
University at Buffalo



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
All-in-One Molecular System
AIO M160
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.